Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,444 | 46,732 | 41,471 | 82,033 | 28,575 |
| Marketable Securities | 156,969 | 227,311 | 176,609 | 37,914 | 24,388 |
| Receivables | 1,230 | 3,374 | 2,430 | 2,274 | N/A |
| TOTAL | $224,493 | $282,780 | $222,502 | $123,119 | $53,575 |
| Non-Current Assets | |||||
| PPE Net | 1,600 | 1,830 | 557 | 860 | 215 |
| Investments And Advances | 0 | 0 | 0 | 3,347 | 2,436 |
| Intangibles | 41,638 | 41,638 | 41,638 | 41,638 | 41,638 |
| Other Non-Current Assets | 15,523 | 13,659 | 3,348 | 340 | 255 |
| TOTAL | $58,761 | $57,127 | $45,543 | $46,185 | $44,544 |
| Total Assets | $283,254 | $339,907 | $268,045 | $169,304 | $98,119 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,598 | 1,731 | 3,693 | 2,124 | 2,368 |
| Accrued Expenses | 16,431 | 13,112 | 9,679 | 6,139 | 4,753 |
| TOTAL | $24,433 | $24,440 | $18,472 | $13,492 | $7,121 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 6,411 | 5,100 | 5,229 | N/A |
| Other Non-Current Liabilities | 6,725 | 9,082 | 0 | 0 | 0 |
| TOTAL | $18,243 | $42,250 | $38,920 | $42,692 | $11,120 |
| Total Liabilities | $42,676 | $66,690 | $57,392 | $56,184 | $18,241 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,186 | 2,718 | 2,128 | 1,687 | 1,438 |
| Common Shares | 34 | 32 | 25 | 20 | 17 |
| Retained earnings | -501,573 | -439,421 | -341,787 | -251,036 | -208,228 |
| Other shareholders' equity | -270 | -201 | -347 | -392 | -601 |
| TOTAL | $240,578 | $273,217 | $210,653 | $113,120 | $79,878 |
| Total Liabilities And Equity | $283,254 | $339,907 | $268,045 | $169,304 | $98,119 |